Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis Review

Date: February 16, 2016
Pages: 55
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C8D8B52275EEN
Leaflet:

Download PDF Leaflet

Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis Review
Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief Summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Cipla Ltd. (Cipla) is a global pharmaceutical company, which undertakes the research, development, manufacturing and commercialization of various active pharmaceutical ingredients (APIs), formulations and animal healthcare products. The company also provides over-the-counter (OTC) products and a range of inhaled medication and devices. It utilizes technology and innovation to cater the daily medical needs of its patients in more than 65 therapeutic areas. Cipla also exports a wide range of raw materials, prescription drugs, OTC, intermediates and veterinary products in more than 170 countries located in Australasia, Middle East, Africa, Europe and North, Central and South America. It has collaborations with academic, industry, healthcare providers, government and non-government organizations to offer its products and services. Cipla is headquartered in Mumbai, Maharashtra, India.

Cipla Ltd. Key Recent Developments

Feb 10, 2016: Cipla Announces Q3 Results & Limited Review Report for the Quarter ended December 31, 2015
Jan 21, 2016: CARE reaffirms ‘CARE AAA / A1+’ rating
Jan 07, 2016: Cipla Announces its Management Council
Nov 07, 2015: Cipla appoints Naina Lal Kidwai as an Independent Director on its Board
Nov 05, 2015: Cipla announces Q2 FY1516 Unaudited Consolidated Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Cipla Ltd. - Key Facts
Cipla Ltd. - Key Employees
Cipla Ltd. - Key Employee Biographies
Cipla Ltd. - Major Products and Services
Cipla Ltd. - Medical Equipment Pipeline Products Data
Cipla Ltd. Pipeline Products by Equipment Type
Cipla Ltd. Pipeline Products by Development Stage
Cipla Ltd. - History
Cipla Ltd. - Company Statement
Cipla Ltd. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Cipla Ltd. - Business Description
Cipla Ltd. - Corporate Strategy
Cipla Ltd. - SWOT Analysis
SWOT Analysis - Overview
Cipla Ltd. - Strengths
Strength - Sturdy Research and Development Activities
Strength - Strong Export Market
Strength - Focus on Respiratory Medicine
Cipla Ltd. - Weaknesses
Weakness - High Cost Structure
Weakness - Manufacturing Issues
Weakness - Patent Infringement Concerns
Cipla Ltd. - Opportunities
Opportunity - Strategic Agreements
Opportunity - Orphan Drug Designation
Opportunity - Inorganic Growth Strategies
Cipla Ltd. - Threats
Threat - Intense Competition
Threat - Uncertain R&D Outcomes
Threat - Stringent Government Regulations
Cipla Ltd. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Cipla Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Cipla Ltd., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Cipla Ltd., Medical Equipment, Deals By Year, 2010 to YTD 2016
Cipla Ltd., Medical Equipment, Deals By Type, 2010 to YTD 2016
Cipla Ltd., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 10, 2016: Cipla Announces Q3 Results & Limited Review Report for the Quarter ended December 31, 2015
Jan 21, 2016: CARE reaffirms ‘CARE AAA / A1+’ rating
Jan 07, 2016: Cipla Announces its Management Council
Nov 07, 2015: Cipla appoints Naina Lal Kidwai as an Independent Director on its Board
Nov 05, 2015: Cipla announces Q2 FY1516 Unaudited Consolidated Financial Results
Oct 21, 2015: FDA Raises Concerns On Cipla's Manufacturing Unit In India
Sep 01, 2015: Cipla appoints Umang Vohra and Prabir Jha to its management team
Aug 14, 2015: Cipla announces Q1 FY1516 Unaudited Consolidated Financial Results
Jul 09, 2015: Cipla Board Announces Appointment of Samina Vaziralli onto the Board of Directors
May 29, 2015: Cipla Announces Q4 & FY15 Results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Cipla Ltd., Key Facts
Cipla Ltd., Key Employees
Cipla Ltd., Key Employee Biographies
Cipla Ltd., Major Products and Services
Cipla Ltd. Number of Pipeline Products by Equipment Type
Cipla Ltd. Pipeline Products by Equipment Type
Cipla Ltd. Number of Pipeline Products by Development Stage
Cipla Ltd. Pipeline Products by Development Stage
Cipla Ltd., History
Cipla Ltd., Subsidiaries
Cipla Ltd., Key Competitors
Cipla Ltd., Ratios based on current share price
Cipla Ltd., Annual Ratios
Cipla Ltd., Interim Ratios
Cipla Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Cipla Ltd., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Cipla Ltd., Medical Equipment, Deals By Year, 2010 to YTD 2016
Cipla Ltd., Medical Equipment, Deals By Type, 2010 to YTD 2016
Cipla Ltd., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Cipla Ltd. Pipeline Products by Equipment Type
Cipla Ltd. Pipeline Products by Development Stage
Cipla Ltd., Performance Chart (2011 - 2015)
Cipla Ltd., Ratio Charts
Cipla Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Cipla Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Cipla Ltd., Medical Equipment, Deals By Year, 2010 to YTD 2016
Cipla Ltd., Medical Equipment, Deals by Type, 2010 to YTD 2016
Skip to top


Ask Your Question

Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: